• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌变过程中的胃微生物组特征:超越幽门螺旋杆菌。

Gastric microbiome profile throughout gastric carcinogenesis: beyond helicobacter.

机构信息

Department of Gastroenterology, Portuguese Oncology Institute - Porto, Porto, Portugal.

Department of Surgery and Physiology, Porto Faculty of Medicine, Porto, Portugal.

出版信息

Scand J Gastroenterol. 2021 Jun;56(6):708-716. doi: 10.1080/00365521.2021.1902560. Epub 2021 Apr 29.

DOI:10.1080/00365521.2021.1902560
PMID:33915074
Abstract

BACKGROUND

Gastric dysbiosis has been hinted as a potential cause of gastric cancer. However, changes in microbiome throughout the major stages of gastric carcinogenesis remain mostly unknown.

OBJECTIVE

To describe gastric microbiome at different stages, analysing for the first time dysbiosis specifically in patients with early gastric cancer (EGC).

METHODS

Cross-sectional study including patients ( = 77) with endoscopically and histologically confirmed normal stomachs (controls;  = 25), advanced atrophic gastritis with intestinal metaplasia (IM;  = 18) and EGC ( = 34). Endoscopic biopsies from antrum and corpus ( = 154) were analyzed. Next-generation sequencing was performed characterizing microbial communities down to the species level based on full-length 16SrRNA gene profiling.

RESULTS

Significant differences were found in the microbiome profile between the groups. Firmicutes were more frequent ( = .012) and Proteobacteria were less frequent ( = .04) both in the IM and EGC when comparing to controls. Relative frequency of , when present, was much higher in the controls (83%) when comparing to the other groups (IM 1%, EGC 27%;  = .006), being the dominant bacteria only in the controls. Dysbiosis was present already and more significantly at the IM stage, with two bacteria progressively increasing from controls to IM then to cancer: from 1.48 to 3.9% ( = .014); and from 19.3 to 33.7% ( = .04), being the EGC dominant bacteria.

CONCLUSIONS

Our results confirm dominancy in non-atrophic stomachs and progressive dysbiosis throughout gastric carcinogenesis. but particularly is significantly increased in patients with EGC. Specific modulation of these bacteria may change gastric cancer risk.

摘要

背景

胃微生态失调已被提示为胃癌的潜在病因。然而,在胃癌发生的主要阶段,微生物组的变化仍知之甚少。

目的

描述不同阶段的胃微生物组,并首次分析早期胃癌(EGC)患者的微生态失调。

方法

这是一项包括内镜和组织学证实的正常胃(对照组;n=25)、伴有肠化生的进展性萎缩性胃炎(IM;n=18)和 EGC(n=34)患者的横断面研究。分析了胃窦和胃体的内镜活检标本(n=154)。基于全长 16SrRNA 基因谱,进行下一代测序以对微生物群落进行特征分析,直至种水平。

结果

各组之间的微生物组谱存在显著差异。与对照组相比,IM 和 EGC 中厚壁菌门更为常见(P=.012),变形菌门较少(P=.04)。在对照组中,当存在时,的相对频率(83%)明显高于其他组(IM 1%,EGC 27%;P=.006),仅在对照组中为优势菌。在 IM 阶段就已经存在且更为显著的微生态失调,两种细菌从对照组到 IM 再到癌症逐渐增加:从 1.48%增加到 3.9%(P=.014);从 19.3%增加到 33.7%(P=.04),在 EGC 中为优势菌。

结论

我们的结果证实了 在非萎缩性胃中的优势地位和在胃癌发生过程中的逐渐失调。但特别是 在 EGC 患者中显著增加。这些细菌的特异性调节可能会改变胃癌的风险。

相似文献

1
Gastric microbiome profile throughout gastric carcinogenesis: beyond helicobacter.胃癌变过程中的胃微生物组特征:超越幽门螺旋杆菌。
Scand J Gastroenterol. 2021 Jun;56(6):708-716. doi: 10.1080/00365521.2021.1902560. Epub 2021 Apr 29.
2
Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.采用 16S rRNA 基因测序技术评估肠上皮化生患者的胃微生物组和宏基因组功能。
Helicobacter. 2019 Feb;24(1):e12547. doi: 10.1111/hel.12547. Epub 2018 Nov 15.
3
Analysis of gastric microbiome reveals three distinctive microbial communities associated with the occurrence of gastric cancer.胃微生物组分析揭示了与胃癌发生相关的三种独特微生物群落。
BMC Microbiol. 2022 Jul 23;22(1):184. doi: 10.1186/s12866-022-02594-y.
4
Evaluation of the Gastric Microbiome in Patients with Chronic Superficial Gastritis and Intestinal Metaplasia.慢性浅表性胃炎和肠化生患者胃微生物群的评估
Chin Med Sci J. 2022 Mar 31;37(1):44-51. doi: 10.24920/003889.
5
Microbiome changes in the gastric mucosa and gastric juice in different histological stages of -negative gastric cancers.不同组织学阶段 - 阴性胃癌胃黏膜和胃液中的微生物组变化。
World J Gastroenterol. 2022 Jan 21;28(3):365-380. doi: 10.3748/wjg.v28.i3.365.
6
Microbiota according to gastric topography in patients with low or high risk of gastric cancer in Nariño, Colombia.哥伦比亚纳里尼奥地区胃癌低风险或高风险患者胃不同部位的微生物群。
Biomedica. 2019 Aug 1;39(Supl. 2):157-171. doi: 10.7705/biomedica.v39i4.4520.
7
Histopathological phenotypes of early gastric cancer and its background mucosa.早期胃癌及其背景黏膜的组织病理学表型。
Biomed Res. 2011 Apr;32(2):127-34. doi: 10.2220/biomedres.32.127.
8
Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice.幽门螺杆菌通过胃癌发生的自杀之旅:非幽门螺杆菌微生物组的作用及其对临床实践的潜在影响。
Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1591-1597. doi: 10.1007/s10096-019-03564-5. Epub 2019 Apr 17.
9
Effect of on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer.在胃癌高发区临朐基于人群的研究:对胃肠道微生物群的影响。
Gut. 2020 Sep;69(9):1598-1607. doi: 10.1136/gutjnl-2019-319696. Epub 2019 Dec 19.
10
Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis.根除作用下调胃癌发生过程中细胞凋亡抑制蛋白2
Gut Liver. 2017 Jan 15;11(1):79-86. doi: 10.5009/gnl15585.

引用本文的文献

1
Helicobacter pylori, microbiota and gastric cancer - principles of microorganism-driven carcinogenesis.幽门螺杆菌、微生物群与胃癌——微生物驱动致癌作用的原理
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):296-313. doi: 10.1038/s41575-025-01042-2. Epub 2025 Feb 26.
2
Gastric Microbiota Associated with Gastric Precancerous Lesions in -Negative Patients.幽门螺杆菌阴性患者中与胃癌前病变相关的胃微生物群
Microorganisms. 2025 Jan 3;13(1):81. doi: 10.3390/microorganisms13010081.
3
Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications-A Literature Review.
胃癌中的胃肠道微生物群:潜在机制与临床应用——文献综述
Cancers (Basel). 2024 Oct 21;16(20):3547. doi: 10.3390/cancers16203547.
4
Gut microbiome alterations during gastric cancer: evidence assessment of case-control studies.胃癌发生过程中的肠道微生物群改变:病例对照研究的证据评估
Front Microbiol. 2024 May 15;15:1406526. doi: 10.3389/fmicb.2024.1406526. eCollection 2024.
5
Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment.食管癌和胃癌相关微生物群的评估:系统评价与质量评估
Cancers (Basel). 2023 May 9;15(10):2668. doi: 10.3390/cancers15102668.
6
Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging.通过炎症将肠道菌群失调与癌前胃部疾病联系起来:比影像学更深入。
Front Immunol. 2023 Mar 31;14:1134785. doi: 10.3389/fimmu.2023.1134785. eCollection 2023.
7
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer.肠道微生物群与癌症放射治疗关系的新见解。
Nutrients. 2022 Dec 22;15(1):48. doi: 10.3390/nu15010048.
8
A literature review on the potential clinical implications of streptococci in gastric cancer.关于链球菌在胃癌中的潜在临床意义的文献综述。
Front Microbiol. 2022 Oct 26;13:1010465. doi: 10.3389/fmicb.2022.1010465. eCollection 2022.
9
The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer.人类肠道微生物群在胃肠道癌症中的新兴作用。
Front Immunol. 2022 Jun 15;13:915047. doi: 10.3389/fimmu.2022.915047. eCollection 2022.
10
16S rRNA sequencing-based evaluation of the protective effects of Hua-Zhuo-Jie-Du on rats with chronic atrophic gastritis.基于 16S rRNA 测序的化浊解毒方对慢性萎缩性胃炎大鼠保护作用的评价。
BMC Complement Med Ther. 2022 Mar 16;22(1):71. doi: 10.1186/s12906-022-03542-z.